JLE

Epileptic Disorders

MENU

Testing blood and CSF in people with epilepsy: a practical guide Volume 22, issue 4, August 2020

  • [Abubakr and Wambacq, 2016] Abubakr A., Wambacq I. Diagnostic value of serum prolactin levels in PNES in the epilepsy monitoring unit. Neurol-Clin Pract. 2016;6:116-119.
  • [Aícua-Rapún et al., 2020] Aícua-Rapún I., André P., Rossetti A.O. Therapeutic drug monitoring of newer antiepileptic drugs: a randomized trial for dosage adjustment. Annal Neurol. 2020;87:22-29.
  • [Alexopoulos and Dalakas, 2013] Alexopoulos H., Dalakas M.C. Immunology of stiff person syndrome and other GADassociated neurological disorders. Exp Rev Clin Immunol. 2013;9:1043-1053.
  • [American Academy of Pediatrics, 2011] American Academy of Pediatrics. Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics. 2011;127:389-394.
  • [Arora et al., 2016] Arora E., Singh H., Gupta Y. Impact of antiepileptic drugs on bone health: Need for monitoring treatment and prevention strategies. J Family Med Prim Care. 2016;5:248-253.
  • [Baulac et al., 2014] Baulac M., Patten A., Giorgi L. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: Results of a phase III randomized double-blind study. Epilepsia. 2014;55:1534-1543.
  • [Baviera et al., 2017] Baviera M., Roncaglioni M.C., Tettamanti M. Diabetes mellitus: a risk factor for seizures in the elderly-a population-based study. Acta Diabetologica. 2017;54:863-870.
  • [Beghi et al., 2010] Beghi E., Carpio A., Forsgren L. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51:1528-1167.
  • [Bien, 2013] Bien C.G. Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: Review of the literature and suggestions for clinical management. Epilepsia. 2013;54:48-55.
  • [Bindoff and Engelsen, 2012] Bindoff L.A., Engelsen B.A. Mitochondrial diseases and epilepsy. Epilepsia. 2012;53:92-7.
  • [Bjornsson, 2008] Bjornsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica. 2008;118:281-90.
  • [Blümcke et al., 2019] Blümcke I., Arzimanoglou A., Beniczky S., Wiebe S. Roadmap for a competency-based educational curriculum in epileptology: report of the Epilepsy Education Task Force of the International League Against Epilepsy. Epileptic Disord. 2019;21:129-40. 2
  • [Brathen et al., 2005] Brathen G., Ben-Menachem E., Brodtkorb E. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol. 2005;12:575-81.
  • [Callaghan et al., 1985] Callaghan N., Kenny R.A., Oneill B., Crowley M., Goggin T. A prospective study between carbamazepine phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry. 1985;48:639-44.
  • [Castilla-Guerra et al., 2006] Castilla-Guerra L., Fernandez-Moreno M.D., Lopez-Chozas J.M., Fernandez-Bolanos R. Electrolytes disturbances and seizures. Epilepsia. 2006;47:1990-8.
  • [Chopra et al., 2012] Chopra A., Kolla B.P., Mansukhani M.P., Netzel P., Frye M.A. Valproate-induced hyperammonemic encephalopathy: an update on risk factors clinical correlates and management. Gen Hosp Psychiatry. 2012;34:290-8.
  • [Dalmau and Graus, 2018] Dalmau J., Graus F. Antibody-mediated encephalitis. New Engl J Med. 2018;378:840-51.
  • [De Giorgis and Veggiotti, 2013] De Giorgis V., Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure. 2013;22:803-11.
  • [Dobson et al., 2018] Dobson R., Cock H.R., Brex P., Giovannoni G. Vitamin D supplementation. Pract Neurol. 2018;18:35-42.
  • [Fowler et al., 2019] Fowler T., Bansal A.S., Lozsadi D. Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting. Seizure. 2019;72:61-70.
  • [Frank et al., 2012] Frank L.M., Shinnar S., Hesdorffer D.C. Cerebrospinal fluid findings in children with fever-associated status epilepticus: results of the consequences of prolonged febrile seizures (FEBSTAT) study. J Pediatrics. 2012;161:1169-U242.
  • [French et al., 2016] French J.A., Lawson J.A., Yapici Z. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3 randomised double-blind placebo-controlled study. Lancet. 2016;388:2153-63.
  • [Garris and Oles, 2005] Garris S.S., Oles K.S. Impact of topiramate on serum bicarbonate concentrations in adults. Annal Pharmacotherapy. 2005;39:424-6.
  • [Gaspard et al., 2018] Gaspard N., Hirsch L.J., Sculier C. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia. 2018;59:745-52.
  • [Gataullina et al., 2015] Gataullina S., Delonlay P., Lemaire E. Seizures and epilepsy in hypoglycaemia caused by inborn errors of metabolism. Dev Med Child Neurol. 2015;57:194-9.
  • [Graus et al., 2016] Graus F., Titulaer M.J., Balu R. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391-404.
  • [Hamed, 2017] Hamed S.A. The effect of antiepileptic drugs on the kidney function and structure. Expert Rev Clin Pharmacol. 2017;10:993-1006.
  • [Harden et al., 2009] Harden C.L., Hopp J., Ting T.Y. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency. report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Epilepsia. 2009;50:1229-36.
  • [Hart et al., 2015] Hart P.H., Lucas R.M., Walsh J.P. Vitamin D in fetal development: findings from a birth cohort study. Pediatrics. 2015;135:E167-73.
  • [Hauser and Beghi, 2008] Hauser W.A., Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008;49:8-12. 1
  • [He et al., 2016] He T., Kaplan S., Kamboj M., Tang Y.-W. Laboratory diagnosis of central nervous system infection. Curr Infect Dis Rep. 2016;18:35.
  • [Illingworth et al., 2011] Illingworth M.A., Hanrahan D., Anderson C.E. Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol. 2011;53:1053-7.
  • [Jacobs et al., 2003] Jacobs D.A., Fung K.M., Cook N.M., Schalepfer W.W., Goldberg H.I., Stecker M.M. Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome. J Neurol Sci. 2003;213:77-82.
  • [Johnson et al., 2014] Johnson K.B., Michelson K.A., Lyons T.W. Pediatric status epilepticus: How common is cerebrospinal fluid pleocytosis in the absence of infection? Seizure. 2014;23:573-5.
  • [Johnson et al., 2010] Johnson N., Henry C., Fessler A.J., Dalmau J. Anti-NMDA receptor encephalitis causing prolonged non-convulsive status epilepticus. Neurology. 2010;75:1480-2.
  • [Kim et al., 2013] Kim D.W., Lee S.Y., Shon Y.M., Kim J.H. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia. 2013;54:e146-9.
  • [Klepper and Leiendecker, 2007] Klepper J., Leiendecker B. GLUT1 deficiency syndrome - 2007 update. Dev Med Child Neurol. 2007;49:707-16.
  • [Kuo et al., 2002] Kuo R.L., Moran E., Kim D.H., Abrahams H.M., White M.D., Lingeman J.E. Topiramate-induced nephrolithiasis. J Endourol. 2002;16:229-31.
  • [Lancaster et al., 2010] Lancaster E., Lai M.Z., Peng X.Y. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen. Lancet Neurol. 2010;9:67-76.
  • [Leach et al., 2012] Leach J.P., Mohanraj R., Borland W. Alcohol and drugs in epilepsy: Pathophysiology presentation possibilities and prevention. Epilepsia. 2012;53:48-57.
  • [Lee et al., 2018] Lee V.L.L., Choo B.K.M., Chung Y.S., Kundap U.P., Kumari Y., Shaikh M.F. Treatment therapy and management of metabolic epilepsy: a systematic review. Int J Mol Sci. 2018;19:20.
  • [Lou Isenberg et al., 2020] Lou Isenberg A., Jensen M.E., Lindelof M. Plasma-lactate levels in simulated seizures – An observational study. Seizure. 2020;76:47-9.
  • [Lowenstein et al., 2014] Lowenstein D.H., Walker M., Waterhouse E. Status epilepticus in the setting of acute encephalitis. Epilepsy Curr. 2014;14:43-9.
  • [Lunardi et al., 2019] Lunardi M., Lin K., Walz R., Wolf P. Single antiepileptic drug levels do not predict adherence and nonadherence. Acta Neurologica Scandinavica. 2019;139:199-203.
  • [Marson et al., 2005] Marson A., Jacoby A., Johnson A., Kim L., Gamble C., Chadwick D. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet. 2005;365:2007-13.
  • [Matz et al., 2016] Matz O., Zdebik C., Zechbauer S. Lactate as a diagnostic marker in transient loss of consciousness. Seizure. 2016;40:71-5.
  • [MHRA, 2009] MHRA. Antiepileptics: adverse effects on bone. Drug Safety Update. 2009;2:2.
  • [Myers et al., 2019] Myers K.A., Johnstone D.L., Dyment D.A. Epilepsy genetics: current knowledge applications and future directions. Clin Genet. 2019;95:95-111.
  • [Nardone et al., 2016] Nardone R., Brigo F., Trinka E. Acute symptomatic seizures caused by electrolyte disturbances. J Clin Neurol. 2016;12:21-33.
  • [Nass et al., 2017] Nass R.D., Sassen R., Elger C.E., Surges R. The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures. Seizure. 2017;47:51-65.
  • [NICE, 2012] NICE. 2012 (Update 2019). The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care: Pharmacological update. London. Available: https://www.nice.org.uk/guidance/cg137 [Accessed 21/12/2018].
  • [Ohara et al., 2017] Ohara N., Koda R., Watanabe H. Generalized status epilepticus in a patient with acute onset type 1 diabetes mellitus associated with severe kidney dysfunction: a case report and literature review. Int Med. 2017;56:1993-9.
  • [Panchaud et al., 2018] Panchaud A., Cohen J.M., Patorno E. Anticonvulsants and the risk of perinatal bleeding complications A pregnancy cohort study. Neurology. 2018;91:E533-42.
  • [Patsalos et al., 2018] Patsalos P.N., Spencer E.P., Berry D.J. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Ther Drug Monit. 2018;40:526-48.
  • [Patsalos et al., 2018] Patsalos P.N., St. Louis E.K. The Epilepsy Prescriber's Guide to Antiepileptic Drugs. Cambridge: Cambridge University Press; 2018.
  • [Pennell, 2003] Pennell P.B. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology. 2003;61:S35-42.
  • [Petit-Pedrol et al., 2014] Petit-Pedrol M., Armangue T., Peng X.Y. Encephalitis with refractory seizures status epilepticus and antibodies to the GABA(A) receptor: a case series characterisation of the antigen and analysis of the effects of antibodies. Lancet Neurol. 2014;13:276-86.
  • [Petrenaite et al., 2005] Petrenaite V., Sabers A., Hansen-Schwartz J. Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res. 2005;65:185-8.
  • [Pirie et al., 2014] Pirie D.A.J., Al Wattar B.H., Pirie A.M. Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;172:26-31.
  • [Pohlmann-Eden et al., 2006] Pohlmann-Eden B., Beghi E., Camfield C., Camfield P. The first seizure and its management in adults and children. Br Med J. 2006;332:339-42.
  • [Rahman, 2012] Rahman S. Mitochondrial disease and epilepsy. Dev Med Child Neurol. 2012;54:397-406.
  • [Riggs, 2002] Riggs J.E. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227-39.
  • [Roth et al., 2017] Roth D.E., Leung M., Mesfin E. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. BMJ. 2017;29:j5237. 359
  • [Sarecka-Hujar et al., 2019] Sarecka-Hujar B., Szołtysek-Bołdys I., Kopyta I., Dolińska B., Sobczak A. Concentrations of the selected biomarkers of endothelial dysfunction in response to antiepileptic drugs: a literature review. Clin Appl Thromb Hemost. 2019;25:1076029619859429.
  • [Schmidt et al., 1983] Schmidt D., Canger R., Avanzini G. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry. 1983;46:751-5.
  • [Scramstad and Jackson, 2017] Scramstad C., Jackson A.C. Cerebrospinal fluid pleocytosis in critical care patients with seizures. Can J Neurol Sci. 2017;44:343-9. 4
  • [Shen et al., 2015] Shen A.L., Lin H.L., Tseng Y.F. Topiramate may not increase risk of urolithiasis: a nationwide population-based cohort study. Seizure. 2015;29:86-9.
  • [Solomon et al., 2012] Solomon T., Michael B.D., Smith P.E. Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64:347-73.
  • [Suleiman et al., 2011] Suleiman J., Brenner T., Gill D. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology. 2011;76:1252-5.
  • [Sveberg et al., 2015] Sveberg L., Vik K., Henriksen T., Tauboll E. Women with epilepsy and post partum bleeding - Is there a role for vitamin K supplementation? Seizure. 2015;28:85-7.
  • [Thangaratinam et al., 2018] Thangaratinam S., Marlin N., Newton S. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. Health Technol Assess. 2018;22:1-152.
  • [Theochari and Cock, 2018] Theochari E., Cock H.R. Bone Health in Epilepsy. In: Mula M., eds. The Comorbidities of Epilepsy. UK: Elsevier; 2018.
  • [Thurman et al., 2011] Thurman D.J., Beghi E., Begley C.E. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 2011;52:2-26.
  • [Titoff et al., 2019] Titoff V., Moury H.N., Titoff I.B., Kelly K.M. Seizures antiepileptic drugs and CKD. Am J Kidney Dis. 2019;73:90-101.
  • [Tomson et al., 2019] Tomson T., Battino D., Bromley R. Executive summary: management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epilepsia. 2019;60:2343-5.
  • [Trinka et al., 2015] Trinka E., Cock H., Hesdorffer D. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-23.
  • [Trinka et al., 2012] Trinka E., Höfler J., Zerbs A. Causes of status epilepticus. Epilepsia. 2012;53:127-38.
  • [van Karnebeek et al., 2016] van Karnebeek C.D.M., Tiebout S.A., Niermeijer J. Pyridoxine-dependent epilepsy: an expanding clinical spectrum. Pediatric Neurol. 2016;59:6-12.
  • [Verrotti et al., 2014] Verrotti A., Scaparrotta A., Grosso S., Chiarelli F., Coppola G. Anticonvulsant drugs and hematological disease. Neurol Sci. 2014;35:983-93.
  • [Wagner et al., 2018] Wagner J.N., Kalev O., Sonnberger M., Krehan I., von Oertzen T.J. Evaluation of Clinical and Paraclinical Findings for the Differential Diagnosis of Autoimmune and Infectious Encephalitis. Front Neurol. 2018;8:434. 9
  • [Williams et al., 2016] Williams D.M., Gallagher M., Handley J., Stephens J.W. The clinical management of hyponatraemia. Postgrad Med J. 2016;92:407-11.
  • [Wilmshurst et al., 2015] Wilmshurst J.M., Gaillard W.D., Vinayan K.P. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia. 2015;56:1185-97.
  • [Wilson et al., 2019] Wilson M.P., Plecko B., Mills P.B., Clayton P.T. Disorders affecting vitamin B-6 metabolism. J Inherit Metab Dis. 2019;42:629-46.